Darouiche R O, Dhir A, Miller A J, Landon G C, Raad I I, Musher D M
Department of Medicine (Infectious Disease Section), VA Medical Center, Houston, TX 77030.
J Infect Dis. 1994 Sep;170(3):720-3. doi: 10.1093/infdis/170.3.720.
To evaluate the adequacy of penetration of antibiotics into biofilm, a novel in vitro model for prosthesis-related infection was developed. Sterile stainless steel orthopedic nuts were incubated with slime-producing Staphylococcus epidermidis. Biofilm-covered nuts were exposed to varying concentrations of vancomycin; then biofilms were harvested. Vancomycin levels in biofilm, as measured by fluorescent polarization immunoassay, far exceeded the MIC and MBC of vancomycin for the organism. Bacterial growth in biofilm was inversely related to vancomycin concentration in biofilm, but even extremely high drug concentrations did not eradicate bacteria embedded in biofilm. The MICs and MBCs for bacteria recovered from biofilm did not differ from those for incubating organisms. Thus, failure of glycopeptide antibiotics to cure prosthesis-related infection is not due to poor penetration of drugs into biofilm but likely due to diminished antimicrobial effect on bacteria in the biofilm environment.
为评估抗生素渗入生物膜的充分性,开发了一种用于假体相关感染的新型体外模型。将无菌不锈钢骨科螺母与产黏液的表皮葡萄球菌一起孵育。将覆盖有生物膜的螺母暴露于不同浓度的万古霉素;然后收获生物膜。通过荧光偏振免疫测定法测得的生物膜中万古霉素水平远远超过该菌的万古霉素最低抑菌浓度(MIC)和最低杀菌浓度(MBC)。生物膜中的细菌生长与生物膜中万古霉素浓度呈负相关,但即使是极高的药物浓度也不能根除嵌入生物膜中的细菌。从生物膜中回收的细菌的MIC和MBC与孵育菌的MIC和MBC没有差异。因此,糖肽类抗生素治疗假体相关感染失败并非由于药物渗入生物膜不佳,而可能是由于在生物膜环境中对细菌的抗菌作用减弱。